Primary Lymphedema and Lymphatic Malformation

Lymphedema ◽  
2017 ◽  
pp. 743-752
Author(s):  
Ningfei Liu
Keyword(s):  
Lymphatic Malformation ◽  
Primary Lymphedema

Primary Lymphedema as a Truncular Lymphatic Malformation

Lymphedema ◽  
2011 ◽  
pp. 419-426
Author(s):  
Byung-Boong Lee ◽  
James Laredo ◽  
Richard F. Neville
Keyword(s):  
Lymphatic Malformation ◽  
Primary Lymphedema

scholarly journals Complex Decongestive Physiotherapy Treats Skin Changes like Hyperkeratosis Caused by Lymphedema

2012 ◽  
Vol 2012 ◽  
pp. 1-4
Author(s):  
Hande Kaba ◽  
Yesim Bakar ◽  
Özlem Çinar Özdemir ◽  
Seda Sertel
Keyword(s):  
Radiation Therapy ◽  
Lymphatic System ◽  
Lymphatic Malformation ◽  
Skin Changes ◽  
Secondary Lymphedema ◽  
Complex Decongestive Physiotherapy ◽  
Primary Lymphedema

Lymphedema is a chronic, progressive, and often debilitating condition. Primary lymphedema is a lymphatic malformation developing during the later stage of lymph angiogenesis. Secondary lymphedema is the result of obstruction or disruption of the lymphatic system, which can occur as a consequence of tumors, surgery, trauma, infection, inflammation, and radiation therapy. Here, we report a 64-year-old woman presenting with hyperkeratosis, a lymphedema due to metastatic uterus carcinoma. In this paper, we present the effects of complex decongestive physiotherapy on lymphedema and hyperkeratosis.

Pregnancy and feto-neonatal outcome in primary lymphedema affected woman

2019 ◽  
Vol 71 (5) ◽  
Author(s):  
Anna F. Cavaliere ◽  
Silvia Perossini ◽  
Maria C. La Milia ◽  
Annalisa Vidiri ◽  
Sandro Michelini ◽  
...  
Keyword(s):  
Neonatal Outcome ◽  
Primary Lymphedema ◽  
Affected Woman

Fetal therapy using rapamycin for a rapidly enlarging, obstructive, cervical lymphatic malformation: a case report

2021 ◽  
Author(s):  
Joel Livingston ◽  
Nouf Alrowaily ◽  
Philip John ◽  
Paolo Campisi ◽  
Sebastian Ranguis ◽  
...  
Keyword(s):  
Case Report ◽  
Lymphatic Malformation ◽  
Fetal Therapy

Congenital Lymphatic Malformation and Aortic Aneurysm in a Patient with TSC2 Mutation

2019 ◽  
Vol 51 (01) ◽  
pp. 057-061 ◽  
Author(s):  
Adelheid Wiemer-Kruel ◽  
Hans Mayer ◽  
Peter Ewert ◽  
Stefan Martinoff ◽  
Hans-Henning Eckstein ◽  
...  
Keyword(s):  
Adverse Effect ◽  
Side Effects ◽  
Aortic Aneurysm ◽  
Tuberous Sclerosis ◽  
Somatic Growth ◽  
Lymphatic Malformation ◽  
Aortic Aneurysms ◽  
Operative Intervention

AbstractWe present a 7-year-old boy with tuberous sclerosis and congenital segmental lymphedema (CSL) of the left leg, as well as two aortic aneurysms. He was treated with everolimus (EVE) since the age of 14 months. His CSL regressed under treatment with EVE. His first aneurysms required operative intervention at age of 17 months. Four months afterward a new aortic aneurysm had been detected above the Dracon graft, but this one remained stable since that time. The patient didn't experience severe side effects. EVE has been well tolerated without disturbance of somatic growth or serious adverse effect.

scholarly journals Lymphatic Malformation Responsive to Sirolimus in Keratinocytic Epidermal Nevus Syndrome with KRAS Mutation: A Case and Brief Literature Discussion

2021 ◽  
pp. 195-201
Author(s):  
Emily Sideris ◽  
Er Tsing Vivian Tng ◽  
Paul Chee
Keyword(s):  
Current Literature ◽  
Kras Mutation ◽  
Rare Case ◽  
Mtor Inhibitor ◽  
Vascular Malformations ◽  
Lymphatic Malformation ◽  
Literature Discussion ◽  
Lymphatic Malformations ◽  
Epidermal Nevus ◽  
Overgrowth Syndromes

We present a rare case of KRAS keratinocytic epidermal nevus syndrome with lymphatic malformation, responsive to treatment with sirolimus, an mTOR inhibitor. A brief review of the current literature regarding sirolimus use in vascular malformations, lymphatic malformations, regional overgrowth syndromes, and RASopathies is discussed.

Sign in / Sign up

Export Citation Format

Share Document